drugset
drugset / Trial / NCT01928472

Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

NCT01928472 ↗

Phase 1 Completed 402 enrolled Novartis Vaccines
RandomizedParallel-groupSingle-blindPrevention

Summary

Evaluate the safety and immunogenicity of four different doses of H7N9 vaccination in adults between the ages of 18 years and 65 years.

Timeline

Start
2013-08
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject H7N9c Vaccine — —

Indications

avian influenza